Germline DNA variations in breast cancer predisposition and prognosis: A systematic review of the literature

Cytogenetic and Genome Research

Volumn 144, Issue 2, 2014, Pages 77-91

  Sapkota, Yadav ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Breast cancer; Breast cancer recurrence; CN LOH; CNVs; Genetic interactions; Genome wide association study; Heritability; Linkage disequilibrium; SNPs; Susceptibility

Indexed keywords

BABM1 PROTEIN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KRUPPEL LIKE FACTOR 4; POU5F1B PROTEIN; PROTEIN; PROTEIN MDMX; RAD51B PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ALLELE; BREAST CANCER; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; COPY NUMBER VARIATION; DIAGNOSTIC TEST ACCURACY STUDY; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; GERMLINE MUTATION; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PENETRANCE; PROGNOSIS; RISK FACTOR;

BREAST NEOPLASMS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERM-LINE MUTATION; HUMANS; PENETRANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84911460875     PISSN: 14248581     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000369045     Document Type: Review

References (144)

1. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, et al: Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41: 585-590 (2009
2. Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ: A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15: 1306-1310 (2006
3. Al-Sukhni W, Joe S, Lionel AC, Zwi ngerman N, Zogopoulos G, et al: Identification of germline genomic copy number variation in familial pancreatic cancer. Hum Genet 131: 1481-1494 (2012
4. Amir E, Freedman OC, Seruga B, Eva ns DG: Assessing women at high risk of breast cancer: A review of risk assessment models. J Natl Cancer Inst 102: 680-691 (2010
5. Anonymous: On beyond GWAS (editorial). Nat Genet 42: 551 (2010
6. Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF: Risk models for familial ovarian and breast cancer. Genet Epidemiol 18: 173-190 (2000).
7. Antoniou AC Pharoa h PD McMullan G Day NE Stratton MR et al A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.Br J Cancer 86 76-83(2002).
8. Antoniou AC, Cunningham A P, Peto J, Evans DG, Lalloo F, et al: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: Updates and extensions. Br J Cancer 98: 1457-1466 (2008 a
9. Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, et al: Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: Validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Ge net 45: 425-431 (2008b
10. Antoniou AC, Wang X, Fredericksen ZS, Mc-Guffog L, Tarrell R, et al: A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42: 885-892 (2010
11. Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, et al: A genome-wide association stud y of prognosis in breast cancer. Cancer Epidemiol Biomarkers Prev 19: 1140-1143 (2010a
12. Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, et al: Association between a germline OCA2 polymorphi sm at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 102: 650-662 (2010b
13. Bau DT, Fu YP, Chen ST, Cheng TC, Yu JC, et al: Breast cancer risk and the DN A doublestrand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1 . Cancer Res 64: 5013-5019 (2004
14. Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, et al: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2 , and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20: 2701-2712 (2002
15. Bewick MA, Conlon MS, Lafrenie RM: Polymorphisms in XRCC1, XRCC3 , and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 24: 5645-5651 (2006).
16. Bodmer W, Tomlinson I: Rare genetic variants and the risk of cancer. Curr Opin Genet Dev 20: 262-267 (2010
17. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, et al: Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 45: 371e2-384e2 (2013
18. Bondy ML, Newman LA: Assessing breast cancer risk: Evolution of the Gail model. J Natl Cancer Inst 98: 1172-1173 (2006
19. Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG: Validation of a breast cancer risk assessment model in w omen with a positive family history. J Natl Cancer Inst 86: 620-625 (1994
20. Borresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, et al: Screening for germ line TP53 mutations in b reast cancer patients. Cancer Res 52: 3234-3236 (1992
21. Cai Q, Long J, Lu W, Qu S, Wen W, et al: Genomewide association study identifies breast cancer risk variant at 10q21.2: Results from the A sia Breast Cancer Consortium. Hum Mol Genet 20: 4991-4999 (2011
22. Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, et al: Interactions between genetic variants and breast cancer ris k factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst 103: 1252-1263 (2011
23. CHEK2 Breast Cancer Case-Control Consortium: CHEK2 1100delC and susceptibility to breast cancer: A colla borative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74: 1175-1182 (2004
24. Chen GK, Jorgenson E, Witte JS: An empirical evaluation of the common disease-common variant hypothesis. BMC Proc 1, Suppl 1:S5 (2007
25. Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies in cluding 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358: 1389-1399 (2001
26. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, et al: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91: 1541-1548 (1999
27. Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, et al: Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 9:e1003212 (2013).
28. Cox A Dunning AM Garcia-Closas M Balasubramanian S Reed MW et al A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39 352-358(2007).
29. Dinu I, Mahasirimongkol S, Liu Q, Yanai H, Sharaf Eldin N, et al: SNP-SNP interactions discovered by logic regression explain Crohn's disease genetics. PLoS One 7:e43035 (2012
30. Dunning AM, Healey CS, P haroah PD, Teare MD, Ponder BA, Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8: 843-854 (1999
31. Easton DF: How many more breast c ancer predisposition genes are there? Breast Cancer Res 1: 14-17 (1999
32. Easton DF, Bishop DT, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52: 678-701 (1993
33. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 265-271 (1995
34. Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, et al: A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81: 873-883 (2007a
35. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093 (2007 b
36. Economopoulos KP, Sergentanis TN: XRCC3 Thr241Met polymorphism and breast cancer risk: A meta-analysis. Breast Cancer Res Treat 121: 439-443 (2010
37. Eich ler EE, Flint J, Gibson G, Kong A, Leal SM, et al: Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11: 446-450 (2010
38. Evans DG, Eccles DM, Rahman N, Young K, Bulman M, et al: A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41: 474-480 (2004
39. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, et al: Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 97: 273-282 (2005
40. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, et al: Novel breast cancer susceptibility locus at 9q31.2: Results of a genome-wide association study. J Natl Cancer Inst 103: 425-435 (2011
41. For d D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692-695 (1994
42. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689 (1998
43. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2 : Analysis of 10,000 individuals. J Clin Oncol 20: 1480-1490 (2002
44. French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, et al: Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression thr ough long-range enhancers. Am J Hum Genet 92: 489-503 (2013
45. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886 (1989
46. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, et al: Heterogeneity of breast cancer ass ociations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4:e1000054 (2008
47. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, et al: Genome-wide association studies identify four ER negativespecific breast cancer risk loci. Nat Genet 45: 392-398, 398e1-2 (2013
48. Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, et al: Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet 6:e1001183 (2010).
49. Gaudet MM Kuchenbaecker KB Vijai J Klein RJ Kirchhoff T et al Identifi cation of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.PLoS Genet9:e1003173(2013).
50. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, et al: Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 44: 312-318 (2012
51. Gibson G: Hints of hidden heritability in GWAS. Nat Genet 42: 558-560 (2010
52. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, et al: Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 105: 4340-4345 ( 2008
53. Haiman CA, Hsu C, de Bakker PI, Frasco M, Sheng X, et al: Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple popu lations. Hum Mol Genet 17: 825-834 (2008
54. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, et al: A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative br east cancer. Nat Genet 43: 1210-1214 (2011
55. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689 (1990
56. Hemminki K, Fö rsti A, Bermejo JL: The ' common disease-common variant' hypothesis and familial risks. PLoS One 3:e2504 (2008
57. Henrichsen CN, Chaignat E, Reymond A: Copy number variants, diseases and gene expression. Hum Mol Genet 18:R1-R8 (2009
58. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, et al: A Catalog of Published Genome-Wide Association Studies (2009). http://www.genome.gov/gwastudies (accessed July 11, 2014
59. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874 (2007
60. International HapMap Consortium: The International HapMap Project. Nature 426: 789-796 (2003
61. Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, et al: Breast cancer: A candidate gene approach across the estrogen metabolic pathway. Breast Cance r Res Treat 108: 137-149 (2008
62. Kastan MB, Bartek J: Cell-cycle checkpoints and cancer. Nature 432: 316-323 (2004
63. Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol 2: 133-140 (2001
64. Kim HC, Lee JY, Sung H, Choi JY, Park SK, et al: A genome-wide association stu dy identifies a breast cancer risk variant in ERBB4 at 2q34: Results from the Seoul Breast Cancer Study. Breast Cancer Res 14:R56 (2012
65. Kryh H, Caren H, Erichsen J, Sjöberg RM, Abrahamsson J, et al: Comp rehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors. BMC Genomics 12: 443 (2011
66. Kuiper RP, Ligtenb erg MJ, Hoogerbrugge N, Geurts Van Kessel A: Germline copy number variation and cancer risk. Curr Opin Genet Dev 20: 282-289 (2010
67. Lapunzina P, Monk D: The consequences of uniparental disomy and copy number neutral loss-of-heterozygosity during human development and cancer. Biol Cell 103: 303-317 (2011
68. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67 (1997
69. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al: Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. New Engl J Med 343: 78-85 (2000
70. Lin WY, Camp NJ, Cannon-Albright LA, Allen-Brady K, Balasubramanian S, et al: A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet 48: 477-484 (2011).
71. Lipponen P Aaltomaa S Kosma VM Syrjänen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A 2068-2073(1994).
72. Locke DP, Sharp AJ, McCa rroll SA, McGrath SD, Newman TL, et al: Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet 79: 275-290 (2006
73. Long J, Cai Q, Shu XO, Qu S, Li C, et al: Identification of a functional genetic variant at 16q12.1 for breast cancer risk: Results from the Asia Breast Cancer Consortium. PLoS Genet 6:e1001002 (2010
74. Long J, Cai Q, Sung H, Shi J, Zhang B, et al: Genome-wide association study in East Asians identifies novel susceptibility loci for breast cancer. PLoS Genet 8:e1002532 (2012
75. Malkin D, Li FP, Str ong LC, Fraumeni JF Jr, Nelson CE, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238 (1990
76. Mangoni M, Bisanzi S, Car ozzi F, Sani C, Biti G, et al: Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3 , and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 81: 52-58 (2011
77. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al: Finding the missing heritability of complex diseases. Nature 461: 747-753 (2009
78. McCarroll SA, Altshuler DM: Copy-number variation and association studies of human disease. Nat Genet 39:S37-42 (2007
79. McCarroll SA, Kuruvilla FG, Korn JM, Cawley S, Nemesh J, et al: Integrated d etection and population-genetic analysis of SNPs and copy number variation. Nat Genet 40: 1166-1174 (2008
80. Melcher R, Hartmann E, Zopf W, Herterich S, Wilke P, et al: LOH and copy neutral LOH ( cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability. Carcinogenesis 32: 636-642 (2011
81. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, et al: Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45: 353-361, 361e1-2 (2013
82. Milne RL, Gaudet MM, Spurdle AB, Fasch ing PA, Couch FJ, et al: Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: A combined case-control study. Breast Cancer Res 12:R110 (2010
83. Mitra AK, Singh N, Singh A, Garg VK, Agarwal A, et al: Association of polymorphisms in base excision repair genes with the risk of breast cancer: A ca se-control study in North Indian women. Oncol Res 17: 127-135 (2008
84. Mohamedali A, Gaken J, Twine NA, Ingram W, Westwood N, et al: Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood 11 0: 3365-3373 (2007
85. Montpetit A, Nelis M, Laflamme P, Magi R, Ke X, et al: An evaluation of the performance of tag SNPs derived from HapMap in a Caucasian population. PLoS Genet 2:e27 (2006
86. Moore JH: The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56: 73-82 (2003
87. Moore JH: A global view of epistasis. Nat Genet 37: 13-14 (2005
88. Nickels S, Truong T, Hein R, Stevens K, Buck K, et al: Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk f actors. PLoS Genet 9:e1003284 (2013
89. O'Keefe C, McDevitt MA, Maciejewski JP: Copy neutral loss of heterozygosity: A novel chromosomal lesion in myeloid malignancies. Blood 115: 2731-2739 (2010
90. Onay VU, Briollais L, Knight JA, Shi E, Wang Y, et al: SNP-SNP interactions in breast cancer susceptibility. BMC Cancer 6: 114 (2006
91. Orr N, Lemnrau A, Coo ke R, Fletcher O, Tomczyk K, et al: Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet 44: 1182-1184 (2012).
92. Palanca Suela S Esteban Cardenosa E Barragan Gonzalez E de Juan Jiménez I Chirivella González I et al CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast Cancer Res Treat 119 87-93(2010).
93. Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK: Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74: 1-5 (1996).
94. Peto J, Collins N, Barfoot R, Seal S, Warren W, et al: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943-949 (1999
95. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31: 33-36 (2002
96. Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA; SEARCH Investigators: Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3:e42 (2007
97. Pharoah PD, Antoni ou AC, Easton DF, Ponder BA: Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358: 2796-2803 (2008
98. Piccolo SR, Camp N, Frey LJ: Polygenic model for predicting breast cancer risk via genome-wide polymorphisms. AMIA Annu Symp Proc 1094 (2008
99. Pooley KA, Baynes C, Driver KE, Tyrer J, Azzato EM , et al: Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev 17: 3482-3489 (2008
100. Rafiq S, Tapper W, Collins A, K han S, Politopoulos I, et al: Identification of inherited genetic variations influencing prognosis in early-onset breast cancer. Cancer Res 73: 1883-1891 (2013
101. Rahman N, Seal S, Thompson D, Kell y P, Renwick A, et al: PALB2 , which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39: 165-167 (2007
102. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al: Global variation in copy number in the human genome. Nature 444: 444-454 (2006
103. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, et al: Linkage disequilibrium in the human genome. Nature 411: 199-204 (2001
104. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, et al: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Ge net 38: 873-875 (2006
105. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA: Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Ca ncer Inst 93: 358-366 (2001
106. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, et al: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409: 928-933 (2001
107. Saeki H, Kitao H, Yoshinaga K, Nakanoko T, Kubo N, et al: Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas a ssociated with p53 mutations. Clin Cancer Res 17: 1731-1740 (2011
108. Sapkota Y, Robson P, Lai R, Cass CE, Mackey JR, Damaraju S: A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility. Eur J Hum Genet 20: 682-689 (2012
109. Sapkota Y, Ghosh S, Lai R, Coe BP, Cass CE, et al: Germline DNA co py number aberrations identified as potential prognostic factors for breast cancer recurrence. PLoS One 8:e53850 (2013a
110. Sapkota Y, Mackey JR, Lai R, Franco-Villalobos C, Lupichuk S, et al: Assessi ng SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One 8:e64896 (2013b
111. Sapkota Y, Yasui Y, Lai R, Sridharan M, Robson PJ, et al: Identification of a breast cancer susceptibility locus at 4q31.22 using a genomewide association study paradigm. PLoS One 8:e62550 (2013c
112. Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, et al: A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30: 4330-4336 (2012).
113. Schneider BP Radovich M Sledge GW Robarge JD Li L et al Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 111 157-163(2008).
114. Schonfel d SJ, Bhatti P, Brown EE, Linet MS, Simon SL, et al: Polymorphisms in oxidative stress and inflammation pathway genes, lowdose ionizing radiation, and the risk of breast cancer among US radiologic technologists. Cancer Causes Control 21: 1857-1866 (2010
115. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, et al: Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38: 1239-1241 (2006
116. Sehl ME, Langer LR, Papp JC, Kwan L, Seldon JL, et al: Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial br east cancer. Clin Cancer Res 15: 2192-2203 (2009
117. Sehrawat B, Sridharan M, Ghosh S, Robson P, Cass CE, et al: Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility. Hum Genet 130: 529-537 (2011
118. Shlien A, Malkin D: Copy number variations and cancer susceptibility. Curr Opin Oncol 22: 55-63 (2010
119. Shu XO, Long J, Lu W, Li C, Chen WY, et al: Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res 72: 1182-1189 (2012
120. Sidd iq A, Couch FJ, Chen GK, Lindströ m S, Eccles D, et al: A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 21: 5373-5384 (2012
121. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, et al: A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45: 646-655 (2006
122. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, et al: Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29: 2132-2138 (2008
123. Solom on E, Ledbetter DH: Report of the committee on the genetic constitution of chromosome 17. Cytogenet Cell Genet 55: 198-215 (1990
124. Spiegelman D, Colditz GA, Hunter D, Hertzmark E: Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 86: 600-607 (1994
125. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, et al: Common variants on ch romosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869 (2007
126. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, et al: Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40: 703-706 (2008).
127. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, et al: Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 16: 1140-1147 (2007
128. Stram DO: Tag SNP selection for association studies. Genet Epidemiol 27: 365-374 (2004
129. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315: 848-853 (2007
130. Thoma s D: Gene-environment-wide association studies: Emerging approaches. Nat Rev Genet 11: 259-272 (2010
131. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, et al: A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) . Nat Genet 41: 579-584 (2009
132. Thompson D, Easton DF, Breast Cancer Linkage Consortium: Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94: 1358-1365 (2002
133. Tice JA, Miike R, Adduci K, Petrakis NL, King E, Wrensch MR: Nipple aspirate fluid cytology and the Gail model for breast ca ncer risk assessment in a screening population. Cancer Epidemiol Biomarkers Prev 14: 324-328 (2005
134. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al: Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507 (2010).
135. Tuzun E Sharp AJ Bailey J.A Kaul R Morrison VA et al Fine-scale structural variation of the human genome. Nat Genet 37 727-732(2005).
136. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23: 1111-1130 (2004
137. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, et al: Performance of common genetic variants in breast-cancer risk models. New Engl J Med 362: 986-993 (2010
138. Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, et al: Association of genetic variation in genes implicated in the betacatenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 17: 2101-2108 (2008
139. Wellcome Trust Case Control Consortium, Craddock N, Hurles ME, Cardin N, Pearson RD, et al: Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464: 713-720 (2010
140. Wong KK, deLeeuw RJ, Dosanjh NS, Kimm LR, Cheng Z, et al: A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 80: 91-104 (2007
141. Wooster R, Bignell G, Lanc aster J, Swift S, Seal S, et al: Identification of the breast cancer susceptibility gene BRCA2 . Nature 378: 789-792 (1995
142. Yoshihara K, Tajima A, Adachi S, Quan J, Sekine M, et al: Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer 50: 167-177 (2011
143. Zheng W, Long J, Gao YT, Li C, Zheng Y, et al: Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41: 324-328 (2009
144. Zuk O, Hechter E, Sunyaev SR, Lander ES: The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci USA 109: 1193-1198 (2012